Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle. 2012

Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
Division of Clinical Virology, Kobe University Graduate School of medicine, Kobe, Japan.

Human herpesvirus 6 (HHV-6) is a T-cell-tropic betaherpesvirus. HHV-6 can be classified into two variants, HHV-6 variant A (HHV-6A) and HHV-6B, based on genetic, antigenic, and cell tropisms, although the homology of their entire genomic sequences is nearly 90%. The HHV-6A glycoprotein complex gH/gL/gQ1/gQ2 is a viral ligand that binds to the cellular receptor human CD46. Because gH has 94.3% amino acid identity between the variants, here we examined whether gH from one variant could complement its loss in the other. Recently, we successfully reconstituted HHV-6A from its cloned genome in a bacterial artificial chromosome (BAC) (rHHV-6ABAC). Using this system, we constructed HHV-6ABAC DNA containing the HHV-6B gH (BgH) gene instead of the HHV-6A gH (AgH) gene in Escherichia coli. Recombinant HHV-6ABAC expressing BgH (rHHV-6ABAC-BgH) was successfully reconstituted. In addition, a monoclonal antibody that blocks HHV-6B but not HHV-6A infection neutralized rHHV-6ABAC-BgH but not rHHV-6ABAC. These results indicate that HHV-6B gH can complement the function of HHV-6A gH in the viral infectious cycle.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005816 Genetic Complementation Test A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell. Allelism Test,Cis Test,Cis-Trans Test,Complementation Test,Trans Test,Allelism Tests,Cis Tests,Cis Trans Test,Cis-Trans Tests,Complementation Test, Genetic,Complementation Tests,Complementation Tests, Genetic,Genetic Complementation Tests,Trans Tests
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
September 1997, The Journal of general virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
April 2003, Journal of virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
March 1993, The Journal of general virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
July 1999, The new microbiologica,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
August 1996, Virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
September 1988, Journal of virological methods,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
November 1993, Journal of virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
April 1989, Mikrobiyoloji bulteni,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
February 1999, Journal of medical virology,
Hiroko Oyaizu, and Huamin Tang, and Megumi Ota, and Nobuyuki Takenaka, and Keiichi Ozono, and Koichi Yamanishi, and Yasuko Mori
March 2008, Neurology,
Copied contents to your clipboard!